284 related articles for article (PubMed ID: 24312006)
1. Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.
Bowerman M; Vincent T; Scamps F; Perrin FE; Camu W; Raoul C
Front Cell Neurosci; 2013 Nov; 7():214. PubMed ID: 24312006
[TBL] [Abstract][Full Text] [Related]
2. Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia.
Motataianu A; Barcutean L; Balasa R
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):159-166. PubMed ID: 31903792
[TBL] [Abstract][Full Text] [Related]
3. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis.
Rizzo F; Riboldi G; Salani S; Nizzardo M; Simone C; Corti S; Hedlund E
Cell Mol Life Sci; 2014 Mar; 71(6):999-1015. PubMed ID: 24100629
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic CD8
Coque E; Salsac C; Espinosa-Carrasco G; Varga B; Degauque N; Cadoux M; Crabé R; Virenque A; Soulard C; Fierle JK; Brodovitch A; Libralato M; Végh AG; Venteo S; Scamps F; Boucraut J; Laplaud D; Hernandez J; Gergely C; Vincent T; Raoul C
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2312-2317. PubMed ID: 30674678
[TBL] [Abstract][Full Text] [Related]
5. How Degeneration of Cells Surrounding Motoneurons Contributes to Amyotrophic Lateral Sclerosis.
Crabé R; Aimond F; Gosset P; Scamps F; Raoul C
Cells; 2020 Nov; 9(12):. PubMed ID: 33260927
[TBL] [Abstract][Full Text] [Related]
6. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
7. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor-II and leukemia inhibitory factor antibody immunostaining on the ionized calcium-binding adaptor molecule 1-positive microglias in the spinal cord of amyotrophic lateral sclerosis patients.
Kihira T; Suzuki A; Kubo T; Miwa H; Kondo T
Neuropathology; 2007 Jun; 27(3):257-68. PubMed ID: 17645240
[TBL] [Abstract][Full Text] [Related]
9. Death Receptors in the Selective Degeneration of Motoneurons in Amyotrophic Lateral Sclerosis.
Aebischer J; Bernard-Marissal N; Pettmann B; Raoul C
J Neurodegener Dis; 2013; 2013():746845. PubMed ID: 26316997
[TBL] [Abstract][Full Text] [Related]
10. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses.
Béland LC; Markovinovic A; Jakovac H; De Marchi F; Bilic E; Mazzini L; Kriz J; Munitic I
Brain Commun; 2020; 2(2):fcaa124. PubMed ID: 33134918
[TBL] [Abstract][Full Text] [Related]
11. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
Zhao W; Beers DR; Appel SH
J Neuroimmune Pharmacol; 2013 Sep; 8(4):888-99. PubMed ID: 23881705
[TBL] [Abstract][Full Text] [Related]
12. The microglial component of amyotrophic lateral sclerosis.
Clarke BE; Patani R
Brain; 2020 Dec; 143(12):3526-3539. PubMed ID: 33427296
[TBL] [Abstract][Full Text] [Related]
13. Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis.
Liu Z; Cheng X; Zhong S; Zhang X; Liu C; Liu F; Zhao C
Front Neurosci; 2020; 14():575. PubMed ID: 32612503
[TBL] [Abstract][Full Text] [Related]
14. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
El Oussini H; Bayer H; Scekic-Zahirovic J; Vercruysse P; Sinniger J; Dirrig-Grosch S; Dieterlé S; Echaniz-Laguna A; Larmet Y; Müller K; Weishaupt JH; Thal DR; van Rheenen W; van Eijk K; Lawson R; Monassier L; Maroteaux L; Roumier A; Wong PC; van den Berg LH; Ludolph AC; Veldink JH; Witting A; Dupuis L
Acta Neuropathol; 2016 Mar; 131(3):465-80. PubMed ID: 26744351
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
[TBL] [Abstract][Full Text] [Related]
16. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.
Liao B; Zhao W; Beers DR; Henkel JS; Appel SH
Exp Neurol; 2012 Sep; 237(1):147-52. PubMed ID: 22735487
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system in amyotrophic lateral sclerosis.
Bilsland LG; Greensmith L
Curr Pharm Des; 2008; 14(23):2306-16. PubMed ID: 18781981
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis.
Chiarotto GB; Nardo G; Trolese MC; França MC; Bendotti C; Rodrigues de Oliveira AL
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104236
[TBL] [Abstract][Full Text] [Related]
19. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.
Thonhoff JR; Ojeda L; Wu P
Curr Stem Cell Res Ther; 2009 Sep; 4(3):178-99. PubMed ID: 19492980
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
